Traditional risk estimates for atherosclerotic vascular disease (ASVD) and death may
not perform optimally in the setting of CKD. We sought to determine whether the addition
of measures of inflammation and kidney function to traditional estimation tools improves
prediction of these events in a diverse cohort of patients with CKD. Observational
cohort study 2399 Chronic Renal Insufficiency Cohort (CRIC) study participants without
history of cardiovascular disease at study entry. Baseline plasma levels of biomarkers
of inflammation (interleukin (IL)-1β, IL-1RA (IL-1 receptor antagonist), IL-6, tumor
necrosis factor (TNF)-α, transforming growth factor β (TGFβ), high sensitivity C-Reactive
protein (hs-CRP), fibrinogen, and serum albumin), measures of kidney function (estimated
glomerular filtration rate (eGFR) and albuminuria), and the Pooled Cohort Equation
Probability (PCEP) estimate. Composite of ASVD events (incident myocardial infarction
(MI), peripheral arterial disease (PAD), and stroke) and death. Cox proportional hazard
models adjusted for PCEP estimates, albuminuria, and eGFR. During a median follow-up
of 7.3 years, 86, 61, 48, and 323 participants experienced MI, PAD, stroke, or death,
respectively. 1-decile greater levels of IL-6 (adjusted Hazard Ratio [aHR], 1.12;
95% CI, 1.08-1.16; p<0.001), TNF-α (aHR, 1.09; 95% CI, 1.05-1.13; p<0.001), fibrinogen
(aHR, 1.07; 95% CI, 1.03-1.11; p<0.001), and serum albumin (aHR, 0.96; 95% CI, 0.93-0.99;
p<0.002) were independently associated with the composite ASVD-death outcome. A composite
inflammation score (CIS) incorporating these four biomarkers was associated with a
graded increase in risk for the composite outcome. The incidence of ASVD-death increased
across the quintiles of risk derived from PCEP, kidney function, and CIS. The addition
of eGFR, albuminuria, and CIS to PCEP improved (p=0.003) the area under the receiver
operating characteristic curve for the composite outcome from 0.68 (95% CI, 0.66-0.71)
to 0.73 (95% CI, 0.71-0.76). Data on cardiovascular death were not available. Biomarkers
of inflammation and measures of kidney function are independently associated with
incident ASVD events and death in CKD patients. Traditional cardiovascular risk estimates
could be improved by adding markers of inflammation and measures of kidney function.